Atlas Venture Life Science Advisors, LLC Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$791.0M
Holdings
17
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KYMRKymera Therapeutics, Inc. | 6,875,698 | $291.0M | 36.79% | |
| 2 | DYNDyne Therapeutics, Inc. | 8,934,902 | $86.1M | 10.89% | |
| 3 | DAWNDay One Biopharmaceuticals, Inc. | 8,201,638 | $81.4M | 10.29% | |
| 4 | GBIOGBXGeneration Bio, Co. | 8,278,876 | $60.8M | 7.68% | |
| 5 | AVTEAerovate Therapeutics, Inc. | 3,103,879 | $56.9M | 7.19% | |
| 6 | REPLReplimune Group, Inc. | 3,209,627 | $54.5M | 6.89% | |
| 7 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $41.0M | 5.19% | |
| 8 | AKROAkero Therapeutics, Inc. | 2,232,251 | $31.7M | 4.00% | |
| 9 | —Ikena Oncology, Inc. | 5,018,178 | $30.6M | 3.87% | |
| 10 | XLOXilio Therapeutics, Inc. | 2,759,344 | $19.5M | 2.47% | |
| 11 | —Magenta Therapeutics, Inc. | 3,476,536 | $10.1M | 1.27% | |
| 12 | SPROSpero Therapeutics, Inc. | 1,031,160 | $9.0M | 1.13% | |
| 13 | —Gemini Therapeutics, Inc. | 5,254,365 | $7.3M | 0.92% | |
| 14 | —AvroBio, Inc. | 4,520,863 | $6.0M | 0.75% | |
| 15 | —F-star Therapeutics, Inc. | 599,524 | $2.1M | 0.27% | |
| 16 | VRDNViridian Therapeutics, Inc. | 90,072 | $1.7M | 0.21% | |
| 17 | COGTCogent Biosciences, Inc. | 186,487 | $1.4M | 0.18% |